FGF23 and neurofibromatosis type 1: Our results tend to exclude a FGF23/αKlotho pathway derangement in NF1 children thus suggesting that the BMD reduction found in a consistent proportion of these patients is not FGF23-driven or that FGF23 impairment can occur later in life.